Catalyst Wire Dossier Catalyst Wire Dossier

CD19-targeted CAR-T cell therapy

· Chongqing Precision Biotech Co., Ltd
Drug timelines are a Plus or Pro feature.

16 regulatory and trial events tracked for CD19-targeted CAR-T cell therapy, covering 2016-09-07 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: CAR-T Immunotherapy Targeting CD19- ALL [Phase 1, Phase 2]

See pricing